Navigation Links
UTSA infectious disease researchers advancing vaccine against Valley fever
Date:7/7/2009

San Antonio Medical mycologists in The South Texas Center for Emerging Infectious Diseases (STCEID) and the Department of Biology at The University of Texas at San Antonio (UTSA) have significantly advanced the fight against San Joaquin Valley Fever, a respiratory infection of humans, commonly called Valley Fever, which is caused by the Coccidioides fungus. For the first time, the researchers have genetically engineered a live, attenuated vaccine that successfully protects mice against Valley Fever, known in scientific circles as coccidioidomycosis.

A live, attenuated vaccine is used as a preventative treatment based upon creation of a mutated form of the pathogen that is no longer capable of causing disease.

Coccidioides, a soil-dwelling fungus, is responsible for significantly increased numbers of respiratory infections among outdoor workers when compared to the general population. In addition, people with compromised T-cell immunity, the elderly and certain racial groups, such as African-Americans and Filipinos who live in the Southwestern United States, have an increased incidence of the infection's symptoms, caused by the inhalation of Coccidioides spores.

In approximately 40% of human Valley Fever cases, respiratory problems set in one to three weeks after inhalation. Although less than one percent of infected individuals experience severe symptoms, such as chronic-progressive pneumonia or meningitis, the incidence of reported primary pulmonary infection cases in Arizona and California is on the rise, having significantly increased in the last decade.

STCEID researchers at UTSA and Wilford Hall Medical Center at San Antonio's Lackland Air Force Base have long collaborated on Coccidioides studies in the hopes of developing a vaccine to better protect those who are exposed to it in the future. This most recent study has been funded by the National Institute of Allergy and Infectious Diseases, the California HealthCare Foundation and the Margaret Batts Tobin Foundation.

"Respiratory infections caused by Coccidioides tend to escape the radar of most large pharmaceutical companies, because only about 100,000 cases are reported each year," said Garry Cole, professor of biology at UTSA and the study's principal investigator.

He adds, "But when I look at 100,000 cases, I see 100,000 faces looking back at me."


'/>"/>

Contact: Christi Fish
christi.fish@utsa.edu
210-458-7584
University of Texas at San Antonio
Source:Eurekalert

Related biology news :

1. Northwestern to expose most deadly infectious diseases in 3-D
2. BWF awards $7 million to infectious disease investigators
3. ASM and FIND to partner on strengthening infectious disease diagnosis in developing nations
4. Scientists use remote satellite imaging to predict outbreaks of infectious disease
5. NSF, NIH award Ecology of Infectious Disease grants
6. World leaders in infectious diseases convene to discuss emerging global viruses
7. NIAID scientists to speak on range of infectious disease topics at major scientific meeting
8. The medium is the message: Manipulating salmonella in spaceflight curtails infectiousness
9. Team identifies a molecular switch linking infectious disease and depression
10. Ecologists question effects of climate change on infectious diseases
11. UCI awarded $45 million for infectious disease research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
Breaking Biology News(10 mins):
(Date:6/16/2017)... (PRWEB) , ... June 16, 2017 , ... ... device compliance and commercialization, has just announced two more sessions of its “From ... series will focus on the world of online templates for design control exercises. ...
(Date:6/15/2017)... ... June 15, 2017 , ... The newest ... artist’s journey through creative experimentation and interdisciplinary collaboration. Feature Creep, a solo exhibition ... An opening reception will be held at EKG, located at 3600 Market Street ...
(Date:6/14/2017)... ... June 14, 2017 , ... The Thailand Board ... announces that they’re co-hosting a delegation from Thailand at BIO 2017 in San ... industry gathering in the world, regroups more than 1,100 biotech companies, academic institutions, ...
(Date:6/14/2017)... June 14, 2017   Micralyne Inc., ... a primary supplier of sensors, is pleased to ... Placentia, California to develop and manufacture ... The joint development of this technology leverages the ... truly flexible and cost effective Metal TSV solution ...
Breaking Biology Technology: